Copied
 
 
2022, DKK
31.05.2023
Bruttoresultat

1.296''

Primær drift

989''

Årets resultat

908''

Aktiver

11.442''

Kortfristede aktiver

5.570''

Egenkapital

2.048''

Afkastningsgrad

9 %

Soliditetsgrad

18 %

Likviditetsgrad

61 %

Resultat
31.05.2023
Årsrapport
2022
31.05.2023
2021
05.07.2022
2020
06.08.2021
2019
29.05.2020
2018
29.05.2019
2017
31.05.2018
2016
31.05.2017
2015
01.06.2016
Nettoomsætning4.942.000.0003.737.000.0003.430.000.0003.584.000.0003.467.000.0003.465.000.0003.615.000.0003.693.000.000
Bruttoresultat1.296.000.000710.000.000720.000.00000000
Resultat af primær drift989.000.000253.000.000234.000.000319.000.000285.000.000302.000.000527.000.000380.000.000
Indtægter af kapitalandele (tilknyttede og associerede) 414.000.0000000109.000.0003.784.000.0000
Finansielle indtægter331.000.00074.000.00061.000.00087.000.00089.000.000100.000.00091.000.000157.000.000
Finansieringsomkostninger-514.000.000-329.000.000-59.000.000-58.000.000-67.000.000-418.000.000-62.000.000-216.000.000
Andre finansielle omkostninger00000000
Resultat før skat1.204.000.0001.396.000.0001.162.000.0001.975.000.000892.000.00093.000.0004.340.000.000589.000.000
Resultat908.000.0001.148.000.0001.124.000.0001.792.000.000799.000.000-231.000.0003.729.000.000497.000.000
Forslag til udbytte0000-1.525.000.000000
Aktiver
31.05.2023
Årsrapport
2022
31.05.2023
2021
05.07.2022
2020
06.08.2021
2019
29.05.2020
2018
29.05.2019
2017
31.05.2018
2016
31.05.2017
2015
01.06.2016
Kortfristede varebeholdninger869.000.000534.000.000504.000.000561.000.000465.000.000422.000.000366.000.000426.000.000
Kortfristede tilgodehavender fra salg og tjenesteydelser 3.176.000.0005.133.000.0004.048.000.0001.945.000.0002.110.000.0002.389.000.0003.059.000.0002.988.000.000
Likvider1.525.000.000509.000.000404.000.000554.000.0002.989.000.0002.523.000.0002.812.000.0003.444.000.000
Kortfristede aktiver5.570.000.0006.176.000.0004.956.000.0003.060.000.0005.564.000.0005.334.000.0006.237.000.0006.858.000.000
Immaterielle aktiver og goodwill54.000.00074.000.00094.000.000116.000.000145.000.000171.000.000211.000.000273.000.000
Finansielle anlægsaktiver4.762.000.0004.768.000.0008.096.000.0005.557.000.0003.435.000.0003.455.000.0005.494.000.0005.421.000.000
Materielle aktiver1.056.000.000944.000.000948.000.000947.000.000859.000.000809.000.000811.000.000784.000.000
Langfristede aktiver5.872.000.0005.786.000.0009.138.000.0006.620.000.0004.439.000.0004.435.000.0006.516.000.0006.478.000.000
Aktiver11.442.000.00011.962.000.00014.094.000.0009.680.000.00010.003.000.0009.769.000.00012.753.000.00013.336.000.000
Aktiver
31.05.2023
Passiver
31.05.2023
Årsrapport
2022
31.05.2023
2021
05.07.2022
2020
06.08.2021
2019
29.05.2020
2018
29.05.2019
2017
31.05.2018
2016
31.05.2017
2015
01.06.2016
Forslag til udbytte00001.525.000.000000
Egenkapital2.048.000.0003.662.000.0002.514.000.0004.321.000.0004.054.000.0003.291.000.0005.313.000.0006.336.000.000
Hensatte forpligtelser00021.000.0004.000.0000487.000.0000
Langfristet gæld til banker00000000
Anden langfristet gæld00000000
Leverandører af varer og tjenesteydelser684.000.000605.000.000415.000.000422.000.000459.000.000404.000.000342.000.000314.000.000
Kortfristede forpligtelser9.073.000.0007.930.000.0006.855.000.0005.231.000.0005.790.000.0006.276.000.0006.717.000.0006.717.000.000
Gældsforpligtelser9.394.000.0008.300.000.00011.580.000.0005.338.000.0005.945.000.0006.478.000.0006.953.000.0007.000.000.000
Forpligtelser9.394.000.0008.300.000.00011.580.000.0005.338.000.0005.945.000.0006.478.000.0006.953.000.0007.000.000.000
Passiver11.442.000.00011.962.000.00014.094.000.0009.680.000.00010.003.000.0009.769.000.00012.753.000.00013.336.000.000
Passiver
31.05.2023
Nøgletal
31.05.2023
Årsrapport
2022
31.05.2023
2021
05.07.2022
2020
06.08.2021
2019
29.05.2020
2018
29.05.2019
2017
31.05.2018
2016
31.05.2017
2015
01.06.2016
Afkastningsgrad 8,6 %2,1 %1,7 %3,3 %2,8 %3,1 %4,1 %2,8 %
Dækningsgrad 26,2 %19,0 %21,0 %Na.Na.Na.Na.Na.
Resultatgrad 18,4 %30,7 %32,8 %50,0 %23,0 %-6,7 %103,2 %13,5 %
Varelagerets omsætningshastighed 5,7 7,0 6,8 6,4 7,5 8,2 9,9 8,7
Egenkapitals-forretning 44,3 %31,3 %44,7 %41,5 %19,7 %-7,0 %70,2 %7,8 %
Payout-ratio Na.Na.Na.Na.190,9 %Na.Na.Na.
Gældsdæknings-nøgletal 192,4 %76,9 %396,6 %550,0 %425,4 %72,2 %850,0 %175,9 %
Soliditestgrad 17,9 %30,6 %17,8 %44,6 %40,5 %33,7 %41,7 %47,5 %
Likviditetsgrad 61,4 %77,9 %72,3 %58,5 %96,1 %85,0 %92,9 %102,1 %
Resultat
31.05.2023
Gæld
31.05.2023
Årsrapport
31.05.2023
Nyeste:01.01.2022- 31.12.2022(offentliggjort: 31.05.2023)
Oplysning om eventualaktiver:Contingent assets related to Intercompany ReceivablesAs a result of tax audits the Danish Tax Authorities have issued final and draft assessments, increasing the taxable income of DuPont Nutrition Biosciences ApS for the years under audit. Following this and within the allowed timeline, the Company has entered into Mutual Agreement Procedures related to these increases of taxable income to avoid double taxation. Once an agreement is reached with the adjusting jurisdictions, the Company may invoice the related parties in those jurisdictions which can lead to an additional intra-group income of up to DKK 4,2 billion to be included in "Other operating income". No income is recognized, as it is not deemed virtually certain, as a Mutual Agreement Procedure is a lengthy process, with associated significant uncertainty surrounding the duration and outcome of the process.  
Beretning
31.05.2023
Beskrivelse af usikkerhed ved indregning eller måling:The Company's subsidiaries are recognized at cost and amount to MDKK 5. 151. Their value is assessed on an ongoing basis, however, this assessment contains a number of estimates and assumptions that may change and thus affect the overall value. Impairment recognized by the end of December is MDKK 698 and is unchanged compared to 31 December 2021. The Danish Tax Authorities have initiated a transfer pricing audit of DuPont Nutrition Biosciences ApS, and the Company has incorporated a provision for this ongoing tax audit and related cost. In case of a material increase of the taxable income resulting from this audit, DuPont Nutrition Biosciences ApS will seek to enter into Mutual Agreement Procedures to avoid double taxation, and the Company has recognized a contingent asset related to this. The provision and contingent asset has been made on the basis of management’s best estimate, and is therefore subject to material uncertainty.
Beskrivelse af usædvanlige forhold, der kan have påvirket indregningen eller målingen:DuPont Nutrition Biosciences ApS´s policy is to ensure the highest standards of ethics and integrity in everything we do, this includes all data used by the Company. All data is protected and can only be accessed by employees with relevant business purpose. DuPont Nutrition Biosciences ApS døs not use datånalysis, algorithms, datarobots, Artificial Intelligence, or similar as part of the business of the company. Information security tools are in place to deter threat actors, block malicious emails and avoid IT system interruptions. We regularly evaluate the effectiveness of our systems and test our contingency plans by conducting vulnerability analyses, including simulated information security incidents. As part of the annual Code of Conduct training all employees are trained in the importance of data security and data integrity. Sensitive data is protected and only available to relevant functions on a strict need-to-know basis. Our Code of Conduct supports ethical decision-making when using data.  
Statement by Management on the annual report
Identifikation af den godkendte årsrapport:Today, the Board of Directors and the Executive Board have discussed and approved the annual report of DuPont Nutrition Biosciences ApS for the financial year 1 January - 31 December 2022.
Management's review
Beskrivelse af virksomhedens væsentligste aktiviteter:DuPont Nutrition Biosciences ApS is an indirectly owned subsidiary of International Flavours & Fragrances Inc. at 31 December 2022, and sells bio-based ingredients for use in food and beverages and industrial enzymes to a wide range of industries. The majority of the products are sold on the European market and are products within the Nourish Division. This Division sells cultures, emulsifiers, functional solutions, protein solutions, natural food protection, which are mainly used in culinary, snacks, dairy, bakery, bars & confectionery, and beverage industries. Further the Company has activities within Research and Development, Production, Distribution and a range of administrative functions. On the production sites placed in Grindsted and Haderslev, we manufacture products within emulsifiers, standardised textural ingredients, cultures, functional solutions, and enzymes. DuPont Nutrition Biosciences ApS is the parent company for a number of subsidiaries and the owner of IP rights within bio-based food ingredients developed by DuPont Nutrition Biosciences ApS and subsidiaries.
Vi bruger cookies til at øge oplevelsen og målrette vores markedsføring.
Ved at klikke OK tillader du brug af cookies. Læs mere her.
OK